Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,310
archived clinical trials in
Allergy

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
Study 200165, A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Compare the Efficacy of a 2-Week Treatment With Fluticasone Propionate Nasal Spray Versus Cetirizine in Adult Subjects With Seasonal Allergic Rhinitis (SAR)
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
San Antonio, TX
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
Study 200165, A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Compare the Efficacy of a 2-Week Treatment With Fluticasone Propionate Nasal Spray Versus Cetirizine in Adult Subjects With Seasonal Allergic Rhinitis (SAR)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
Study 200165, A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Compare the Efficacy of a 2-Week Treatment With Fluticasone Propionate Nasal Spray Versus Cetirizine in Adult Subjects With Seasonal Allergic Rhinitis (SAR)
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Waco, TX
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
Study 200165, A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Compare the Efficacy of a 2-Week Treatment With Fluticasone Propionate Nasal Spray Versus Cetirizine in Adult Subjects With Seasonal Allergic Rhinitis (SAR)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Waco, TX
Click here to add this to my saved trials
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
Study 200165, A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Compare the Efficacy of a 2-Week Treatment With Fluticasone Propionate Nasal Spray Versus Cetirizine in Adult Subjects With Seasonal Allergic Rhinitis (SAR)
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
South Burlington, VT
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
Study 200165, A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Compare the Efficacy of a 2-Week Treatment With Fluticasone Propionate Nasal Spray Versus Cetirizine in Adult Subjects With Seasonal Allergic Rhinitis (SAR)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
South Burlington, VT
Click here to add this to my saved trials
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
Study 200165, A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Compare the Efficacy of a 2-Week Treatment With Fluticasone Propionate Nasal Spray Versus Cetirizine in Adult Subjects With Seasonal Allergic Rhinitis (SAR)
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Greenfield, WI
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
Study 200165, A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Compare the Efficacy of a 2-Week Treatment With Fluticasone Propionate Nasal Spray Versus Cetirizine in Adult Subjects With Seasonal Allergic Rhinitis (SAR)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Greenfield, WI
Click here to add this to my saved trials
Examination of the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma Severity
The Purpose of This Study is to Examine the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma Severity
Status: Enrolling
Updated:  12/31/1969
USF
mi
from
Tampa, FL
Examination of the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma Severity
The Purpose of This Study is to Examine the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma Severity
Status: Enrolling
Updated: 12/31/1969
USF
mi
from
Tampa, FL
Click here to add this to my saved trials
Scratch and Sleep Quantification in Atopic Dermatitis
Quantification of Scratch and Sleep in Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Scratch and Sleep Quantification in Atopic Dermatitis
Quantification of Scratch and Sleep in Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients
A Controlled Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Pruritus in Adult Hemodialysis Patients
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences, Dermatology
mi
from
Winston-Salem, NC
Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients
A Controlled Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Pruritus in Adult Hemodialysis Patients
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences, Dermatology
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Molekule for Allergic Rhinitis/Asthma
Molekule for Allergic Rhinitis/Asthma
Status: Enrolling
Updated:  12/31/1969
Molekule
mi
from
San Francisco, CA
Molekule for Allergic Rhinitis/Asthma
Molekule for Allergic Rhinitis/Asthma
Status: Enrolling
Updated: 12/31/1969
Molekule
mi
from
San Francisco, CA
Click here to add this to my saved trials
Introduction and Maintenance of Still Eating Protein Blends in Support of Infant Nutritional Goals
Daily Ingestion of a Multi-Allergen Food Supplement by Infants: Clinical Symptoms, Reactions, and Acceptability - A Randomized Trial
Status: Enrolling
Updated:  12/31/1969
Jane L Holl
mi
from
Chicago, IL
Introduction and Maintenance of Still Eating Protein Blends in Support of Infant Nutritional Goals
Daily Ingestion of a Multi-Allergen Food Supplement by Infants: Clinical Symptoms, Reactions, and Acceptability - A Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Jane L Holl
mi
from
Chicago, IL
Click here to add this to my saved trials
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated:  12/31/1969
Hoag Medical Group
mi
from
Huntington Beach, CA
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 12/31/1969
Hoag Medical Group
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Mountain View, CA
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Mountain View, CA
Click here to add this to my saved trials
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated:  12/31/1969
Clinical Research Institute Inc
mi
from
Plymouth, MN
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 12/31/1969
Clinical Research Institute Inc
mi
from
Plymouth, MN
Click here to add this to my saved trials
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated:  12/31/1969
Midwest Clinical Research LLC
mi
from
Saint Louis, MO
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 12/31/1969
Midwest Clinical Research LLC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated:  12/31/1969
Breathe America
mi
from
Albuquerque, NM
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 12/31/1969
Breathe America
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated:  12/31/1969
Northwell Health System
mi
from
Great Neck, NY
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 12/31/1969
Northwell Health System
mi
from
Great Neck, NY
Click here to add this to my saved trials
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated:  12/31/1969
Allergy, Asthma and clinical Research Center
mi
from
Oklahoma City, OK
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 12/31/1969
Allergy, Asthma and clinical Research Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated:  12/31/1969
Carolina ENT
mi
from
Orangeburg, SC
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 12/31/1969
Carolina ENT
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated:  12/31/1969
Memphis & Shelby County Pediatrics
mi
from
Memphis, TN
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 12/31/1969
Memphis & Shelby County Pediatrics
mi
from
Memphis, TN
Click here to add this to my saved trials
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated:  12/31/1969
Houston Clinical Research Associates
mi
from
Houston, TX
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 12/31/1969
Houston Clinical Research Associates
mi
from
Houston, TX
Click here to add this to my saved trials
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated:  12/31/1969
Allergy and Asthma Research Institute
mi
from
Waco, TX
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 12/31/1969
Allergy and Asthma Research Institute
mi
from
Waco, TX
Click here to add this to my saved trials
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Status: Enrolling
Updated:  12/31/1969
Texan Allergy & Sinus Center
mi
from
Austin, TX
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Status: Enrolling
Updated: 12/31/1969
Texan Allergy & Sinus Center
mi
from
Austin, TX
Click here to add this to my saved trials
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Status: Enrolling
Updated:  12/31/1969
Texan Allergy & Sinus Center
mi
from
Grapevine, TX
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Status: Enrolling
Updated: 12/31/1969
Texan Allergy & Sinus Center
mi
from
Grapevine, TX
Click here to add this to my saved trials
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Status: Enrolling
Updated:  12/31/1969
Texan Allergy & Sinus Center
mi
from
San Antonio, TX
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Status: Enrolling
Updated: 12/31/1969
Texan Allergy & Sinus Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Multi-center, Double-blind, Double-dummy, Randomized, Placebo-controlled, Active-reference, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-129968 in Adolescent, Adult & Elderly Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  12/31/1969
Clinical Investigative Site 7905
mi
from
Austin, TX
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Multi-center, Double-blind, Double-dummy, Randomized, Placebo-controlled, Active-reference, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-129968 in Adolescent, Adult & Elderly Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 12/31/1969
Clinical Investigative Site 7905
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Multi-center, Double-blind, Double-dummy, Randomized, Placebo-controlled, Active-reference, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-129968 in Adolescent, Adult & Elderly Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  12/31/1969
Clinical Investigative Site 7907
mi
from
Kerrville, TX
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Multi-center, Double-blind, Double-dummy, Randomized, Placebo-controlled, Active-reference, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-129968 in Adolescent, Adult & Elderly Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 12/31/1969
Clinical Investigative Site 7907
mi
from
Kerrville, TX
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Multi-center, Double-blind, Double-dummy, Randomized, Placebo-controlled, Active-reference, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-129968 in Adolescent, Adult & Elderly Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  12/31/1969
Clinical Investigative Site 7903
mi
from
New Braunfels, TX
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Multi-center, Double-blind, Double-dummy, Randomized, Placebo-controlled, Active-reference, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-129968 in Adolescent, Adult & Elderly Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 12/31/1969
Clinical Investigative Site 7903
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Multi-center, Double-blind, Double-dummy, Randomized, Placebo-controlled, Active-reference, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-129968 in Adolescent, Adult & Elderly Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  12/31/1969
Clinical Investigative Site # 6222
mi
from
San Antonio, TX
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Multi-center, Double-blind, Double-dummy, Randomized, Placebo-controlled, Active-reference, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-129968 in Adolescent, Adult & Elderly Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 12/31/1969
Clinical Investigative Site # 6222
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
A Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group, Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  12/31/1969
Clinical Investigative Site 7905
mi
from
Austin, TX
Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
A Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group, Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 12/31/1969
Clinical Investigative Site 7905
mi
from
Austin, TX
Click here to add this to my saved trials
Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
A Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group, Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  12/31/1969
Clinical Investigative Site 7907
mi
from
Kerrville, TX
Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
A Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group, Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 12/31/1969
Clinical Investigative Site 7907
mi
from
Kerrville, TX
Click here to add this to my saved trials
Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
A Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group, Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  12/31/1969
Clinical Investigative Site 7903
mi
from
New Braunfels, TX
Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
A Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group, Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 12/31/1969
Clinical Investigative Site 7903
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
A Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group, Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  12/31/1969
Clinical Investigative Site # 6222
mi
from
San Antonio, TX
Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
A Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group, Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 12/31/1969
Clinical Investigative Site # 6222
mi
from
San Antonio, TX
Click here to add this to my saved trials
Xolair Treatment for Milk Allergic Children
Xolair (Omalizumab) Enhances Oral Tolerance Induction in Milk Allergic Children
Status: Enrolling
Updated:  12/31/1969
Stanford Uneiversity Medical Center
mi
from
Stanford, CA
Xolair Treatment for Milk Allergic Children
Xolair (Omalizumab) Enhances Oral Tolerance Induction in Milk Allergic Children
Status: Enrolling
Updated: 12/31/1969
Stanford Uneiversity Medical Center
mi
from
Stanford, CA
Click here to add this to my saved trials
Xolair Treatment for Milk Allergic Children
Xolair (Omalizumab) Enhances Oral Tolerance Induction in Milk Allergic Children
Status: Enrolling
Updated:  12/31/1969
Children's Hosptial of Boston
mi
from
Boston, MA
Xolair Treatment for Milk Allergic Children
Xolair (Omalizumab) Enhances Oral Tolerance Induction in Milk Allergic Children
Status: Enrolling
Updated: 12/31/1969
Children's Hosptial of Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model
A Phase 4, Randomized, Double-Masked, Single Center, Placebo-Controlled Adaptive Clinical Trial, Using Prednisolone Sodium Phosphate Ophthalmic Solution, 1%, in Subjects With Allergic Conjunctivitis to Evaluate a Modified Conjunctival Allergen Challenge (CAC) Model
Status: Enrolling
Updated:  12/31/1969
Andover Eye Associates
mi
from
Andover, MA
Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model
A Phase 4, Randomized, Double-Masked, Single Center, Placebo-Controlled Adaptive Clinical Trial, Using Prednisolone Sodium Phosphate Ophthalmic Solution, 1%, in Subjects With Allergic Conjunctivitis to Evaluate a Modified Conjunctival Allergen Challenge (CAC) Model
Status: Enrolling
Updated: 12/31/1969
Andover Eye Associates
mi
from
Andover, MA
Click here to add this to my saved trials
Inhibition of Anaphylaxis by Ibrutinib
Inhibition of Anaphylaxis by Ibrutinib
Status: Enrolling
Updated:  12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Inhibition of Anaphylaxis by Ibrutinib
Inhibition of Anaphylaxis by Ibrutinib
Status: Enrolling
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
DNA Vaccine for Ragweed Allergic Adults
A Phase II Observer-blind, Randomized, Placebo-Controlled Study of the Efficacy, Safety, Tolerability, and Immunogenicity of Subcutaneously Administered Dynavax Amb a 1 Immunostimulatory Oligodeoxyribonucleotide Conjugate (AIC) in Ragweed-Allergic Adults (Sponsor's Protocol NRH01)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
DNA Vaccine for Ragweed Allergic Adults
A Phase II Observer-blind, Randomized, Placebo-Controlled Study of the Efficacy, Safety, Tolerability, and Immunogenicity of Subcutaneously Administered Dynavax Amb a 1 Immunostimulatory Oligodeoxyribonucleotide Conjugate (AIC) in Ragweed-Allergic Adults (Sponsor's Protocol NRH01)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate ASN008 Topical Gel (TG)
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Spaulding Research Clinic, Inc
mi
from
West Bend, WI
Study to Evaluate ASN008 Topical Gel (TG)
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Spaulding Research Clinic, Inc
mi
from
West Bend, WI
Click here to add this to my saved trials
Study to Evaluate ASN008 Topical Gel (TG)
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Certified Research Associates
mi
from
Cortland, NY
Study to Evaluate ASN008 Topical Gel (TG)
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Certified Research Associates
mi
from
Cortland, NY
Click here to add this to my saved trials
Study to Evaluate ASN008 Topical Gel (TG)
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Dermatology Consulting Services
mi
from
High Point, NC
Study to Evaluate ASN008 Topical Gel (TG)
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Dermatology Consulting Services
mi
from
High Point, NC
Click here to add this to my saved trials
Study to Evaluate ASN008 Topical Gel (TG)
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Progressive Clinical Research
mi
from
San Antonio, TX
Study to Evaluate ASN008 Topical Gel (TG)
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Progressive Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate ASN008 Topical Gel (TG)
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Innovaderm Recherches Inc
mi
from
Montréal,
Study to Evaluate ASN008 Topical Gel (TG)
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Innovaderm Recherches Inc
mi
from
Montréal,
Click here to add this to my saved trials
Diesel Exhaust Particles and Leukotriene Production
Diesel Exhaust Particles and Leukotriene Production
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Diesel Exhaust Particles and Leukotriene Production
Diesel Exhaust Particles and Leukotriene Production
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Oklahoma Allergy and Asthma Clinic
mi
from
Oklahoma City, OK
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Oklahoma Allergy and Asthma Clinic
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
MetaClin Research, Inc
mi
from
Austin, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
MetaClin Research, Inc
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Austin Clinical Research
mi
from
Austin, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Austin Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Lovelace Scientific Resources
mi
from
Austin, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Lovelace Scientific Resources
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Kerrville Research Associates
mi
from
Kerrville, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Kerrville Research Associates
mi
from
Kerrville, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
Biogenics Research Institute
mi
from
San Antonio, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
Biogenics Research Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated:  12/31/1969
dgd Research, Inc.
mi
from
San Antonio, TX
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen
Status: Enrolling
Updated: 12/31/1969
dgd Research, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials